Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Solventum Corporation Common Stock (NY:SOLV)

74.13 +0.92 (+1.26%)
Official Closing Price Updated: 7:00 PM EDT, Sep 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Solventum Corporation Common Stock

< Previous 1 2 3 4 5 Next >
3 Value Stocks That Concern Us
Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices. But these hidden gems are few... 
Via StockStory
What Analysts Are Saying About Solventum Stock
 
Via Benzinga
This Eaton Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
 
Via Benzinga
What's going on in today's session: S&P500 movers
Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Monday as we examine the latest happenings in today's session. 
Via Chartmill
Earnings Scheduled For August 7, 2025
 
Via Benzinga
Why Solventum (SOLV) Stock Is Up Today
Shares of healthcare solutions provider Solventum (NYSE:SOLV) jumped 2.3% in the afternoon session after the company announced the early results of its tender offers for outstanding notes and increased... 
Via StockStory
Topics Government World Trade
Discover which S&P500 stocks are making waves on Monday.
Curious about the S&P500 stocks that are in motion on Monday? Join us as we explore the top movers within the S&P500 index during today's session. 
Via Chartmill
3 Low-Volatility Stocks We Keep Off Our Radar
Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets. 
Via StockStory
Surgical Equipment & Consumables - Diversified Stocks Q2 Teardown: Solventum (NYSE:SOLV) Vs The Rest
Let’s dig into the relative performance of Solventum (NYSE:SOLV) and its peers as we unravel the now-completed Q2 surgical equipment & consumables - diversified earnings season. 
Via StockStory
Topics Artificial Intelligence Economy
MediWound Revenue Jumps 43% in Q2
Via The Motley Fool
Which S&P500 stocks have an unusual volume on Thursday?
In today's session, there are S&P500 stocks with remarkable trading volume. Explore the stocks exhibiting unusual volume in Thursday's session. 
Via Chartmill
SOLV Q2 Deep Dive: Product Launches and Execution Drive Outperformance Amid Margin Pressures
Healthcare solutions provider Solventum (NYSE:SOLV) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 3.8% year on year to $2.16 billion. Its non-GAAP profit of $1.69 per... 
Via StockStory
Topics World Trade
Which S&P500 stocks are moving on Monday?
Let's have a look at what is happening on the US markets one hour before the close of the markets on Monday. Below you can find the top S&P500 gainers and losers in today's session. 
Via Chartmill
3 Mid-Cap Stocks We Keep Off Our Radar
Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from... 
Via StockStory
Forecasting The Future: 3 Analyst Projections For Solventum
 
Via Benzinga
Solventum (SOLV) Q2 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings World Trade
Solventum (SOLV) Fiscal Q2 EPS Jumps 8%
Via The Motley Fool
Topics Economy World Trade
Movers and shakers in today's after-hours session for S&P500 stocks?
Wondering what's happening in today's after-hours session with S&P500 stocks? Stay tuned for the latest updates on movers and shakers. 
Via Chartmill
Solventum Corp (NYSE:SOLV) Reports Mixed Q2 2025 Earnings with Strong EPS Beat and Slight Revenue Miss
Solventum Corp (NYSE:SOLV) reported mixed Q2 2025 earnings, beating EPS estimates at $1.69 but slightly missing revenue forecasts. Shares rose 3% post-announcement. 
Via Chartmill
Solventum’s (NYSE:SOLV) Q2: Beats On Revenue
Healthcare solutions provider Solventum (NYSE:SOLV) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 3.8% year on year to $2.16 billion. Its non-GAAP profit of $1.69 per share was... 
Via StockStory
Solventum (SOLV) Reports Earnings Tomorrow: What To Expect
Healthcare solutions provider Solventum (NYSE:SOLV) will be announcing earnings results this Thursday afternoon. Here’s what you need to know. 
Via StockStory
Topics Artificial Intelligence World Trade
ZimVie Doubles — And Then Some — On Its Second Takeover Deal
The Zimmer Biomet spinoff is looking to head for private waters under the fund Archimed. 
Via Investor's Business Daily
3 Cash-Producing Stocks with Questionable Fundamentals
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak... 
Via StockStory
Tandem Diabetes, Solventum, LeMaitre, UFP Technologies, and Artivion Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. The wider market sentiment turned... 
Via StockStory
Topics ETFs Stocks World Trade
1 Value Stock for Long-Term Investors and 2 to Approach with Caution
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are... 
Via StockStory
3 Mid-Cap Stocks with Questionable Fundamentals
Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from... 
Via StockStory
3 Low-Volatility Stocks Facing Headwinds
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere. 
Via StockStory
SOLVENTUM CORP (NYSE:SOLV) - A Strong Technical Setup for Breakout Investors
SOLVENTUM CORP (NYSE:SOLV) shows strong technicals and a high-quality setup, making it a breakout candidate for traders. The stock has outperformed 83% of the market and presents clear support levels. 
Via Chartmill
SOLV Q1 Earnings Call: Margin Headwinds Offset by Volume Growth and Product Momentum
Healthcare solutions provider Solventum (NYSE:SOLV) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 2.7% year on year to $2.07 billion. Its non-GAAP profit of... 
Via StockStory
Topics Economy World Trade
Q1 Rundown: Solventum (NYSE:SOLV) Vs Other Surgical Equipment & Consumables - Diversified Stocks
Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at Solventum (NYSE:SOLV) and its peers. 
Via StockStory
Topics Artificial Intelligence Economy
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.